Strategic Deployment of Kinetic Assay Technologies to Accelerate Covalent Drug Discovery

  • Balancing throughput, cost, and data quality when selecting kinetic potency assay for early-stage covalent discovery
  • Designing kinetic and dose-response assays to support efficient lead generation across diverse activity profiles
  • Adapting assay platforms throughout lead optimization to accurately evaluate increasingly potent covalent compounds